A Cohen

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.

Nancy E. Kemeny, Jessica Conti, A Cohen et al. · Journal of Clinical Oncology · 1994 · 176 citations

Medicine, Oncology, Pharmacology +16

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

Paolo Anderlini, Rima M. Saliba, Sandra Acholonu et al. · Bone Marrow Transplantation · 2005 · 117 citations

Medicine, Hematology, Immunology +15

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

P Anderlini, Sergio Giralt, Börje S. Andersson et al. · Bone Marrow Transplantation · 2000 · 86 citations

Medicine, Hematology, Immunology +15

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia

Prabhas Mittal, Rima M. Saliba, Sergio Giralt et al. · Bone Marrow Transplantation · 2004 · 80 citations

Medicine, Hematology, Oncology +12

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.

Nancy E. Kemeny, A Cohen, Karen Seiter et al. · Journal of Clinical Oncology · 1993 · 77 citations

Medicine, Oncology, Pharmacology +17